VIR 主要統計
高い
9.09
オープン
8.82
取引高
1.68M
低い
8.77
前日終値
8.69
売買代金
14.99M
52週高値
11.66
相対取引高
1.022
変動幅 (%)
3.62%
52週安値
4.16
売買回転率
1.00%
時価総額
1.46B
PER（TTM）
--
PER（年次）
2.234
PBR
1.8
PSR
22.38
1株当たり利益（EPS）
-3.137
配当（TTM）
0
配当利回り
0.00%
発行済株式数
168.65M
通貨単位
USD
VIR 価格パフォーマンス
7 日
30 日
90 日
180 日
年初来
1 年
VIR マネーフロー分布
VIR 日次空売り出来高
VIR ショートインタレスト履歴
VIR 株式スナップショット
As of 2026-07-28, the Vir Biotechnology, Inc. (VIR) stock price today is 8.8. Based on this price, the company has a market capitalization of $1.46B, with a P/E ratio of --.
On 2026-07-28, VIR traded between 8.77 and 9.09. Today’s stock price is 0.34% above the daily low and 3.19% below the daily high, placing VIR 下限付近 its most recent trading range.
Trading volume currently stands at 1.68M, compared with an average daily volume of 1.65M. This suggests that trading activity is 通常水準とほぼ同じ than usual.
Over the past year, Vir Biotechnology, Inc. shares have traded between 4.16 and 11.66. At today’s price, VIR is 111.54% above its 52-week low and 24.53% below its 52-week high.
VIR 関連ニュース
について VIR
企業名
Vir Biotechnology, Inc.
セクター
Health Technology
業種
Biotechnology
取引所
Nasdaq
従業員数
367
ロットサイズ
100
公式サイト
通貨単位
USD
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
Related Stocks
